Judge Determines Apple Watch Blood Oxygen Workaround Doesnt Infringe on Masimo Patents
News Source : iPhone in Canada
News Summary
- A U.S. trade tribunal preliminarily ruled that the Apple Watch is currently not infringing on patents owned by Masimo.
- This follows after a long-running legal battle between the two companies.
- In 2023, the ITC determined that Apple was in violation of Masimo's patents regarding blood oxygen sensing.
- This spun a potential US import ban on Apple’s Series 9 and Ultra 2 smartwatches in December 2023 before Apple earned a temporary pause in exchange for disabling the feature in January 2024.
A U.S. International Trade Commission (ITC) judge has determined that Apples current methods of leveraging blood oxygen sensing on Apple Watch do not infringe on Masimos patents. This follows after [+1595 chars]
Never miss a story from us, subscribe to our newsletter